PerleyMJ, KipnisDM. Plasma insulin response to oral and intravenous glucose; studies in normal and diabetic subjects. J Clin Invest, 1967; 46:1954–1962.
5.
MalherbeC, De GasparoM, De HertoghR, HoeJJ. Circadian variations of blood sugar and plasma insulin levels in man. Diabetologia, 1969; 5:397–404.
6.
LernerRL, PorteD. Acute and steady state insulin response to glucose in non-obese diabetic subjects. J Clin Invest, 1972; 51:1624–1631.
7.
GoodnerCJ, ConwayJ, WerrbachJ. Control of insulin secretion during fasting hyperglycaemia in adult diabetics and in nondiabetic subjects during infusion of glucose. J Clin Invest, 1969; 48:1878–1887.
8.
McCarthyST, HarrisE, TurnerRC. Glucose control of basal insulin secretion in diabetes. Diabetologia, 1977; 13:93–97.
9.
KipnisDM. Insulin secretion in diabetes mellitus. Ann Intern Med, 1968; 69:891–901.
10.
CahillGF. The Banting Memorial Lecture 1971. Physiology of insulin in man. Diabetes, 1971; 20:785–799.
11.
WilliamsRF, GleasonRE, SoeldnerJS. The half-life of endogenous serum immunoreactive insulin in man. Metabolism, 1968; 17:1025–1029.
12.
SherwinRS, KramerK J, TobinJD, InselPA, LiljenquistJE, BermanM, AndresR. A model of the kinetics of insulin in man. J Clin Invest, 1964; 53:1481–1492.
13.
InselPA, LiljenquistJE, TobinJD, SherwinRS, WatkinsP, AndresR, BermanM. Insulin control of glucose metabolism in man: a new kinetic analysis. J Clin Invest, 1975; 55:1057–1066.
BergerM, HalbanPA, AssalJP, OffordRE, VranicM, RenoldAE. Pharmacokinetics of subcutaneously injected tritiated insulin: effects of exercise. Diabetes, 1979; 28,Suppl 1:53–57.
16.
SlamaG, HautecouvertureM, AssanR, TchobroutskyG. One to five days of continuous intravenous insulin infusion on seven diabetic patients. Diabetes, 1974; 23:732–738.
17.
DeckertT, LorupB. Regulation of brittle diabetics by a preplanned insulin infusion program. Diabetologia, 1976; 12:573–579.
18.
GenuthS, MartinP. Control of hyperglycemia in adult diabetics by pulsed insulin delivery. Diabetes, 1977; 26:571–581.
19.
HeppKD, RennerR, FunckeHJ, MehnertH, HaertenR, KresseH. Glucose homeostasis under continuous intravenous insulin therapy in diabetics. Horm Metab Res Suppl, 1977; 7:72–76.
20.
KadishAH. A servomechanism for blood sugar control. Biomed Sci Instrum, 1963; 1:171–176.
21.
KadishAH. Automation control of blood sugar: a servomechanism for glucose monitoring and control. Trans Am Soc Artif Intern Organs, 1963; 9:363–367.
22.
KadishAH. Automation control of blood sugar. I. A servomechanism for glucose monitoring and control. Am J Med Electron, 1964; 3:82–86.
23.
AlbisserAM, LeibelBS, EwartTG, DavidovacZ, BotzCK, ZinggW, SchipperH, GanderR. Clinical control of diabetes by the artificial pancreas. Diabetes, 1974; 23:397–404.
PfeifferEF, ThumC, ClemensAH. The artificial beta cell. A continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system)Horm Metab Res, 1974; 6:339–342.
26.
KernerW, ThumCh, TamasJGY, BeischerW, ClemensAH, PfeifferEF. Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial betacell. Horm Metab Res, 1976; 8:256–261.
27.
ClemensAH, ChangPH, MyersRW. The development of Biostator, a glucose controlled insulin infusion system (GCIIS)Horm Metab Res Suppl, 1977; 7:23–33.
28.
MirouzeJ, SelamJL, PhamTC, CavadoreD. Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetes. Diabetologia, 1977; 13:273–278.
29.
KraegenEW, CampbellLV, ChiaYO, MelerH, LazarusL. Control of blood glucose in diabetics using an artificial pancreas. Aust N Z J Med, 1977; 7:280–286.
30.
KraegenEW, WhitesideR, BellD, ChiaYO, LazarusL. Development of a closed-loop artificial pancreas. Horm Metab Res Suppl, 1979; 8:38–42.
31.
ShichiriM, KawamoriR, YamasakiY, InoueM, ShigetaY, AbeH. Computer algorithm for the artificial pancreatic beta cell. Artif Organs, 1978; 2,Suppl:247–250.
32.
KawamoriR, ShichiriM, GoriyaY, YamasakiY, ShigetaY, AbeH. Importance of insulin secretion based on the rate of change in blood glucose concentration in glucose tolerance, assessed by the artificial beta cell. Acta Endocrinol (Copenh), 1978; 87:339–351.
33.
McArthurJA, JacksonRL. Insulin treatment of juvenile diabetes; observations on the combined use of intermediate and regular insulins. Diabetes, 1956; 5:18–24.
34.
OakleyW, HillD, OakleyN. Combined use of regular and crystalline protamine (NPH) insulins in the treatment of severe diabetes. Diabetes, 1966; 15:219–222.
35.
GokalR, HardingP, TurnerRC. Comparison between the plasma insulin and glucose responses to five different insulin regimes in diabetic patients. Clin Endocrinol, 1977; 7:301–305
36.
PhillipsM, SimpsonRW, HolmanRR, TurnerRC. A simple, rational twice daily insulin regime. Distinction between basal and meal insulin requirements. Q J Med, 1979; 48:493–506.
37.
ParsonsJA, RothwellD, SharpeJE. A miniature syringe pump for continuous administration of drugs and hormones: the Mill Hill infuser. Lancet, 1977; 1:77–78.
38.
PickupJC, KeenH, ParsonsJA, AlbertiKGMM. Continuous subcutaneous insulin infusion: an approach to achieving normoglycemia. Br Med J, 1978; 1:204–207.
39.
TamborlaneWV, SherwinRS, GenelM, FeligP. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med, 1979; 300:573–578.
40.
RennerR, HeppKD, MehnertH, FranetzkiM. Continuous intravenous insulin therapy with a miniaturized open-loop system. Horm Metab Res Suppl, 1979; 7:186–190.
41.
IrsiglerK, KritzH. Long-term continuous intravenous insulin therapy with a portable insulin dosage-regulating apparatus. Diabetes, 1979; 28:196–203.
42.
WolpertH, BlockJ. Hands-on demonstration and discussion of new pump software/hardware. Diabetes Technol Ther, 2005; 7:840–844.
43.
SkladanyMJ, MillerM, GuthermannJS, LudwigCR. Patch-pump technology to manage type 2 diabetes mellitus: hurdles to market acceptance. J Diabetes Sci Technol, 2008; 2:1147–1150.
44.
Centers for Disease Control (CDC). Deaths among diabetic patients using continuous subcutaneous insulin infusion pumps—United States. MMWR Morbid Mortal Wkly Rep, 1982; 31:80–82,87.
45.
Centers for Disease Control (CDC). Update: deaths among patients using continuous subcutaneous insulin infusion pumps—United States. MMWR Morbid Mortal Wkly Rep, 1982; 31:626.
46.
TeutschSM, HermanWH, DwyerDM, LaneJM. Mortality among diabetic patients using continuous subcutaneous insulin infusion pumps. N Engl J Med, 1984; 310:361–368.
47.
MecklenbergRS, BensonEA, BensonJW, FredlundPN, GuinnT, MatzRJ, NielsenRL, SannarCA. Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA, 1984; 252:3265–3269.
48.
Weissberg-BenchellJ, Antisdel-LomaglioJ, SeshadriR. Insulin pump therapy: a meta-analysis. Diabetes Care, 2003; 26:1079–1087.
LauritzenT, Frost-LarsenK, LarsenHW, DeckertT. Steno Study Group. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetes. Lancet, 1983; 1:200–204.
56.
Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial. The Kroc Collaborative Study Group. N Engl J Med, 1984; 311:365–372.
57.
Dahl-JørgensenK, Brinchmann-HansenO, HanssenKF, GanesT, BjoroT, SandvikL, AagenaesO. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J (Clin Res Ed), 1985; 290:811–815.
58.
Feldt-RasmussenB, MathiesenER, HegedusL, DeckertT. Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy. N Engl J Med, 1986; 314:665–670.
59.
ReichardP, Bengt-NilssonB-Y, RosenqvistU. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med, 1993; 329:304–309.
60.
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med, 1993; 329:977–986.
61.
PickupJ, MattockM, KerryS. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ, 2002; 324:705–710.
62.
RetnakaranR, HochmanJ, DeVriesJH, Hanaire-BroutinH, HeineRJ, MelkiV, ZinmanB. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care, 2004; 27:2590–2596.
63.
JeitlerK, HorvathK, BergholdA, GratzerTW, NeeserK, PieberTR, SiebenhoferA. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia, 2008; 51:941–951.
64.
PickupJC, SuttonAJ. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med, 2008; 25:765–774.
65.
FatourechiMM, KudvaYC, MuradMH, ElaminMB, TabiniCC, MontoriVM. Clinical review: hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metabol, 2009; 94:729–740.
66.
MissoML, EgbertsKJ, PageM, O'ConnorD, ShawJ. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev, 2010; 1:CD005103.
67.
PańkowskaE, BłazikM, DziechciarzP, SzypowskaA, SzajewskaH. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes, 2009; 10:52–58.
68.
MukhopadhyayA, FarrellT, FraserRB, OlaB. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol, 2007; 197:447–456.
69.
FarrarD, TuffnellDJ, WestJ. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev, 2007; 3:CD005542.
70.
MonamiM, LamannaC, MarchionniN, MannucciE. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis. Exp Clin Endocrinol Diabetes, 2009; 117:220–222.
71.
ColquittJL, GreenC, SidhuMK, HartwellD, WaughN. Clinical, cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess, 2004; 8,43iii1–171.
72.
CumminsE, RoyleP, SnaithA, GreeneA, RobertsonL, McIntyreL, WaughN. Clinical effectiveness, cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review, economic evaluation. Health Technol Assess, 2010; 14,11iii–iv, xi–xvi1–181.
73.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. TamborlaneWV, BeckRW, BodeBW, BuckinghamB, ChaseHP, ClemonsR, Fiallo-ScharerR, FoxLA, GilliamLK, HirschIB, HuangES, KollmanC, KowalskiAJ, LaffelL, LawrenceJM, LeeJ, MaurasN, O'GradyM, RuedyKJ, TanseyM, TsalikianE, WeinzimerS, WilsonDM, WolpertH, WysockiT, XingD. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med, 2008; 359:1464–1476.
74.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care, 2009; 32:1378–1383.
75.
WeinzimerSA, SteilGM, SwanKL, DziuraJ, KurtzN, TamborlaneWV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care, 2008; 31:934–939.
76.
HovorkaR, AllenJM, ElleriD, ChassinLJ, HarrisJ, XingD, KollmanC, HovorkaT, LarsenAM, NodaleM, De PalmaA, WilinskaME, AceriniCL, DungerDB. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet, 2010; 375:743–751.
77.
PickupJ, KeenH. Continuous subcutaneous insulin infusion at 25 years—evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care, 2002; 25:593–598.
